tirzepatide compounds Tirzepatide / Niacinamide Injection |
Description
The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lillys Zepbound.
The Liraglutide and Semaglutide Market was valued at USD 15.19 billion in 2024 and is projected to reach USD 35.01 billion by 2032, expanding at a CAGR of 11% during the forecast period.
Prescription weight loss medication and peptide therapies
100% Financing and Telehealth Available
All peptides require reconstitution with Bacteriostatic Water (BAC water), sold separately
